Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mannkind Corp (MNKD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 353,044
  • Shares Outstanding, K 118,870
  • Annual Sales, $ 174,760 K
  • Annual Income, $ 125,660 K
  • 36-Month Beta 3.07
  • Price/Sales 2.05
  • Price/Cash Flow 5.00
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.74 +2.55%
on 12/15/17
3.38 -16.86%
on 11/16/17
-0.43 (-13.27%)
since 11/15/17
3-Month
1.80 +56.11%
on 09/27/17
6.96 -59.63%
on 10/10/17
+0.52 (+22.71%)
since 09/15/17
52-Week
0.67 +319.40%
on 05/03/17
6.96 -59.63%
on 10/10/17
-0.19 (-6.33%)
since 12/15/16

Most Recent Stories

More News
Report: Exploring Fundamental Drivers Behind Microsoft, Equinix, Fitbit, INC Research, Progressive, and MannKind -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Microsoft Corporation (NASDAQ:MSFT),...

MSFT : 86.85 (+2.55%)
FIT : 6.30 (-7.62%)
INCR : 41.05 (unch)
PGR : 55.46 (+0.58%)
EQIX : 457.85 (-0.54%)
MNKD : 2.81 (-5.39%)
Implied Volatility Surging for MannKind (MNKD) Stock Options

MannKind (MNKD) needs investors to pay close attention to the stock based on moves in the options market lately.

MNKD : 2.81 (-5.39%)
Today's Research Reports on Trending Tickers: MannKind Corporation and TG Therapeutics

NEW YORK, NY / ACCESSWIRE / November 22, 2017 / U.S. markets closed at record highs on the strength of corporate earnings and a rally from the technology sector. The Dow Jones Industrial Average gained...

TGTX : 8.25 (unch)
MNKD : 2.81 (-5.39%)
MannKind Corporation Reports 2017 Third Quarter Financial Results

MannKind Corporation (NASDAQ:MNKD) today reported financial results for the third quarter and the nine months ended September 30, 2017. Third quarter highlights include:

MNKD : 2.81 (-5.39%)
MannKind Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / MannKind Corporation (NASDAQ: MNKD) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 5:00 PM Eastern...

MNKD : 2.81 (-5.39%)
Unknown BTCY May Have Big Upside Ahead of Likely Near-Term FDA Approval

Drug and Medical Device stocks Appreciate in Value Before Big Clinical Trial Results and Clearances from the FDA or European Medicines Agency Investors who Recognize the Potential "Lightning Strike"...

ALNY : 125.59 (+1.56%)
MNKD : 2.81 (-5.39%)
LIFE : 3.60 (+1.41%)
Unknown BTCY May Have Big Upside Ahead of Likely Near-Term FDA Approval

Drug and Medical Device stocks Appreciate in Value Before Big Clinical Trial Results and Clearances from the FDA or European Medicines Agency Investors who Recognize the Potential "Lightning Strike"...

ALNY : 125.59 (+1.56%)
MNKD : 2.81 (-5.39%)
LIFE : 3.60 (+1.41%)
Key FDA Approvals Paramount Catalyst for Biotech Run Heading Into November

The FDA has approved 34 drugs to date in 2017 after approving 22 novel drugs last year. Many biotech and pharma companies have dealt with the drug development process being lengthy and time-consuming along...

AKTX : 4.17 (+0.97%)
CTXR : 4.70 (+0.21%)
ADMS : 32.58 (+1.56%)
ECYT : 4.41 (-4.34%)
MNKD : 2.81 (-5.39%)
Kirby McInerney LLP Files Securities Class Action Lawsuit against H.C. Wainwright & Co., LLC

The law firm of Kirby McInerney LLP announces that it has filed a class action lawsuit in the United States District Court for the Central District of California against H.C. ...

MNKD : 2.81 (-5.39%)
MannKind Corporation to Hold 2017 Third Quarter Financial Results Conference Call on November 7, 2017

MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) will release its 2017 third quarter financial results on Tuesday, November 7, 2017 and its management will host a conference call to discuss the third quarter...

MNKD : 2.81 (-5.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder...

See More

Key Turning Points

2nd Resistance Point 3.08
1st Resistance Point 2.95
Last Price 2.81
1st Support Level 2.71
2nd Support Level 2.60

See More

52-Week High 6.96
Fibonacci 61.8% 4.56
Fibonacci 50% 3.82
Fibonacci 38.2% 3.07
Last Price 2.81
52-Week Low 0.67

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.